← Back to Search
NSAIDs: ENdocannabinoid Stimulating Anti-inflammatory Drugs?
Published 2012 · Medicine
Download PDFAnalyze on Scholarcy
Read any pharmacology textbook and the message is clear: nonsteroidal anti-inflammatory drugs (NSAIDs) act by inhibiting the activity of cyclooxygenase (COX) and thereby the production of prostaglandins. However, evidence is accumulating that NSAIDs involve the endocannabinoid system in their actions, and that such effects may pave the way towards the design of new analgesics that are not plagued with the gastrointestinal and cardiovascular adverse actions that are associated with this class of drugs. In this Opinion article, our current understanding of the involvement of the endocannabinoid system in the actions of NSAIDs is described, and the ways in which this can lead to novel drug development is discussed.
This paper references
Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2
N. Sawyer (2002)
The Structural Basis of Endocannabinoid Oxygenation by Cyclooxygenase-2*
A. J. Vecchio (2011)
Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen.
C. Fowler (1999)
Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
V. Haller (2006)
Dual COXIB/TP antagonists: a possible new twist in NSAID pharmacology and cardiovascular risk.
G. Rovati (2010)
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
J. Z. Long (2009)
Monoacylglycerol lipase – a target for drug development?
C. Fowler (2012)
Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra- but not intracellular pH
S. Holt (2003)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. Pertwee (2010)
Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship.
C. Fowler (1997)
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.
J. Vane (1971)
Über den K- und Ca-Gehalt von Eiter und Exsudaten und Seine Beziehungen zum Entzündungsschmerz
C. Häbler (2005)
Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain
L. Guasti (2009)
Interaction between cytokines, cannabinoids and the nervous system.
L. Jean-Gilles (2010)
Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside
E. Rahn (2011)
Intracellular Cannabinoid Type 1 (CB1) Receptors Are Activated by Anandamide*
G. Brailoiu (2011)
Differential Sensitivity and Mechanism of Inhibition of COX-2 Oxygenation of Arachidonic Acid and 2-Arachidonoylglycerol by Ibuprofen and Mefenamic Acid†
J. J. Prusakiewicz (2009)
NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies
J. Wallace (2012)
Oxidative metabolism of endocannabinoids.
K. Kozak (2002)
Inhibition of Monoacylglycerol Lipase Attenuates Nonsteroidal Anti-Inflammatory Drug-Induced Gastric Hemorrhages in Mice
S. Kinsey (2011)
Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia
C. Mallet (2008)
Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP‐3
R. Rozenfeld (2008)
Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain
J. Guindon (2006)
Acidic Nonsteroidal Anti-inflammatory Drugs Inhibit Rat Brain Fatty Acid Amide Hydrolase in a pH-dependent Manner
C. Fowler (2003)
Novel bioactive metabolites of dipyrone (metamizol).
T. Rogosch (2012)
TRPV1 in Brain Is Involved in Acetaminophen-Induced Antinociception
C. Mallet (2010)
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions.
O. Sasso (2012)
The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level
G. Horváth (2008)
R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids
P. Bishay (2010)
Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs*
J. Lehmann (1997)
Precaution, cyclooxygenase inhibition, and cardiovascular risk.
J. Ritter (2009)
Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
S. Holt (2007)
Chemistry around imidazopyrazine and ibuprofen: discovery of novel fatty acid amide hydrolase (FAAH) inhibitors.
Frédéric De Wael (2010)
Prostaglandin E2 glycerol ester, an endogenous COX‐2 metabolite of 2‐arachidonoylglycerol, induces hyperalgesia and modulates NFκB activity
S. Hu (2008)
Amino Acid Determinants in Cyclooxygenase-2 Oxygenation of the Endocannabinoid 2-Arachidonylglycerol*
K. Kozak (2001)
A Decrease in Anandamide Signaling Contributes to the Maintenance of Cutaneous Mechanical Hyperalgesia in a Model of Bone Cancer Pain
I. Khasabova (2008)
Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling
M. Bracey (2002)
Endogenous Opioid and Cannabinoid Mechanisms Are Involved in the Analgesic Effects of Celecoxib in the Central Nervous System
R.M. Rezende (2012)
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
S. Trelle (2011)
Conversion of Acetaminophen to the Bioactive N-Acylphenolamine AM404 via Fatty Acid Amide Hydrolase-dependent Arachidonic Acid Conjugation in the Nervous System*
E. Högestätt (2005)
Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors
F. Benedetti (2011)
Synergy between Enzyme Inhibitors of Fatty Acid Amide Hydrolase and Cyclooxygenase in Visceral Nociception
P. S. Naidu (2009)
Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.
N. Ueda (2011)
Effects of COX‐2 inhibition on spinal nociception: the role of endocannabinoids
L. E. Staniaszek (2010)
Inhibitors of fatty acid amide hydrolase reduce carrageenan‐induced hind paw inflammation in pentobarbital‐treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors
S. Holt (2005)
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.
M. Lynch (2011)
Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide
C. Fowler (2013)
Oxidation of the Endogenous Cannabinoid Arachidonoyl Ethanolamide by the Cytochrome P450 Monooxygenases: Physiological and Pharmacological Implications
Natasha T Snider (2010)
Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain
B. Roques (2012)
Intrathecally applied flurbiprofen produces an endocannabinoid‐dependent antinociception in the rat formalin test
M. Ates (2003)
The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs
G. Reid (2003)
The uterus is a potential site for anandamide synthesis and hydrolysis: Differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period
B. Paria (1996)
CB2 receptor‐mediated antihyperalgesia: possible direct involvement of neural mechanisms
M. Beltramo (2006)
Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide.
K. Kozak (2003)
Localization of the Endocannabinoid-Degrading Enzyme Fatty Acid Amide Hydrolase in Rat Dorsal Root Ganglion Cells and Its Regulation after Peripheral Nerve Injury
I. Lever (2009)
Effect of the enantiomers of flurbiprofen, ibuprofen, and ketoprofen on intestinal permeability.
N. M. Davies (1996)
Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons
A. S. Tahim (2005)
Effects of General Anesthesia on Anandamide Blood Levels in Humans
G. Schelling (2006)
Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats
S. Petrosino (2007)
A role for endocannabinoids in indomethacin-induced spinal antinociception.
H. Gühring (2002)
Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids
A. Telleria-Diaz (2010)
Effects of flurbiprofen enantiomers on pain-related chemo-somatosensory evoked potentials in human subjects.
J. Lötsch (1995)
Fatty Acid Amide Hydrolase: From Characterization to Therapeutics
G. Labar (2007)
Cyclooxygenases: structural and functional insights Research on COX structure and function in the authors' laboratory is supported by grants from the National Institutes of Health (CA-89450 and GM-15431). Published, JLR Papers in Press, October 23, 2008.
C. Rouzer (2009)
Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis.
J. Wallace (2009)
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
B. Cravatt (2001)
Functional role of high-affinity anandamide transport, as revealed by selective inhibition.
M. Beltramo (1997)
Effects of URB597, an inhibitor of fatty acid amide hydrolase (FAAH), on analgesic activity of paracetamol.
M. Soukupová (2010)
This paper is referenced by
Identification and characterization of carprofen as a multi-target FAAH / COX inhibitor
Angelo D. Favia (2013)
Inhibition of Endocannabinoid Metabolism by the Metabolites of Ibuprofen and Flurbiprofen
Jessica Karlsson (2014)
Cannabinoid Receptor‐2 Regulates Embryonic Hematopoietic Stem Cell Development via Prostaglandin E2 and P‐Selectin Activity
Virginie Esain (2015)
Inhibition of Fast Nerve Conduction Produced by Analgesics and Analgesic Adjuvants—Possible Involvement in Pain Alleviation
E. Kumamoto (2020)
THE OFFICIAL JOURNAL OF TRAKYA UNIVERSITY FACULTY OF MEDICINE
K. Demirci (2018)
Identification of prostamides, fatty acyl ethanolamines, and their biosynthetic precursors in rabbit cornea[S]
P. Urquhart (2015)
Non-opioid Analgesics and the Endocannabinoid System
R. D. Topuz (2020)
Profiling the Oxylipin and Endocannabinoid Metabolome by UPLC-ESI-MS/MS in Human Plasma to Monitor Postprandial Inflammation
S. Gouveia-Figueira (2015)
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators.
Mireille Alhouayek (2014)
Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor
S. Gouveia-Figueira (2015)
Host-Directed Therapeutic Strategies for Tuberculosis
Afsal Kolloli (2017)
Endocannabinoid system alterations in Alzheimer’s disease: A systematic review of human studies
A. J. Berry (2020)
Analgesics and analgesic adjuvants inhibiting nerve conduction in the frog sciatic nerve —local anesthetics, opioids, α 2 adrenoceptor agonists, antiepileptics, antidepressants and NSAIDs
E. Kumamoto (2019)
Identification and characterization of carprofen as a multitarget fatty acid amide hydrolase/cyclooxygenase inhibitor.
Angelo D. Favia (2012)
Involvement of Spinal CB1 Cannabinoid Receptors on the Antinociceptive Effect of Celecoxib in Rat Formalin Test
M. Rezaei (2016)
Chiral 1,3,4-oxadiazol-2-ones as highly selective FAAH inhibitors.
Jayendra Z Patel (2013)
Involvement of Spinal CB 1 Cannabinoid Receptors on the Antinociceptive Effect of Celecoxib in Rat Formalin Test
M. Rezaei (2016)
Inhibition by non-steroidal anti-inflammatory drugs of compound action potentials in frog sciatic nerve fibers.
Rika Suzuki (2018)
Osteoarthritis of the hand II: chemistry, pharmacokinetics and pharmacodynamics of naproxen, and clinical outcome studies
Garvin J. Leung (2014)
Development and validation of a sensitive UPLC-ESI-MS/MS method for the simultaneous quantification of 15 endocannabinoids and related compounds in milk and other biofluids.
S. Gouveia-Figueira (2014)
Conference on ‘ PUFA mediators : implications for human health ’ Symposium 3 : Cannabinoids in human health Elevating endocannabinoid levels : pharmacological strategies and potential therapeutic applications
R. Pertwee (2014)
Endocannabinoid and N-acylethanolamide levels in rat brain and spinal cord following systemic dipyrone and paracetamol administration.
R. D. Topuz (2019)
Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
R. Pertwee (2014)
The Potential of Inhibitors of Endocannabinoid Metabolism for Drug Development: A Critical Review.
C. Fowler (2015)
Maintenance of the Innate Seizure Threshold by Cyclooxygenase-2 is Not Influenced by the Translational Silencer, T-cell Intracellular Antigen-1
Yifan Gong (2018)
Adolescent social rejection alters pain processing in a CB1 receptor dependent manner
P. Schneider (2016)